Wednesday, May 22, 2013

Actavis to buy Warner Chilcott for $5bn

All-stock deal brings an end to a recent series of merger talks around Actavis and will create a speciality pharma group with an annual $11bn in sales

Read more from Financial Times


View the original article here

Posted by Chris Holman at 5:46 AM

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)